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An Investigation of the Role of Microsomal Oxidative Metabolism in the in Vivo Genotoxicity 
of 1,2-Dichloroethane. STORER, R. D.. AND CONOLLY, R. B. (1985). Toxicol. Appl. Pharmacol. 
77,36-46. In vitro studies have demonstrated that two different metabolic pathways, glutathione 
conjugation mediated by the glutathione S-transferases and microsomal oxidation, may be 
involved in the genotoxicity and carcinogenicity of 1,2-dichloroethane (DCE). To evaluate the 
importance of microsomal oxidative metabolism in the bioactivation of DCE in vivo, male 
B6C3F1 mice were pretreated with piperonyl butoxide (PIB), an inhibitor of microsomal 
oxidative metabolism, and the effect of this pretreatment on the extent of hepatic DNA damage 
produced by DCE was determined 4 hr after DCE administration. The in vivo genotoxicity of 
2-chloroethanol, a product of the microsomal oxidative metabolism of DCE, was also 
investigated. Hepatic DNA damage was measured with a sensitive, alkaline DNA unwinding 
assay for the presence of single-strand breaks and alkali-labile lesions in DNA. Pretreatment of 
mice with PIB to inhibit microsomal oxidative metabolism significantly potentiated the hepatic 
DNA damage observed 4 hr after a single, 200-mg/kg, ip dose of DCE. Treatment of mice 
with single, ip doses of 2-chloroethanol as high as 1.2 mmol/kg failed to produce any evidence 
of single-strand breaks and/or alkali-labile lesions in hepatic DNA. When diethyl maleate 
(DEM) was used to deplete hepatic ghrtathione levels prior to administration of 2-chloroethanol, 
the acute hepatotoxicity of 2-chloroethanol was potentiated but again there was no evidence of 
hepatic DNA damage. These results indicate that microsomal, oxidative metabolism of DCE 
to 2-chloroethanol and/or 2 chloroacetaldehyde is not responsible for the hepatic DNA damage 
observed in these studies after DCE administration. 8 1985 Academic press. IW. 
1,2-Dichloroethane (DCE) is an economically 
important, chlorinated, aliphatic hydrocarbon 
used primarily in the production of vinyl 
chloride and other halogenated organics and 
as a solvent, gasoline additive, and compo- 
nent of fumigants. The National Cancer In- 
stitute (USDHEW, 1978) has determined 
that DCE is carcinogenic to Osborne-Mendel 
rats and B6C3FI mice when administered 
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chronically by gavage. A second bioassay of 
DCE for possible carcinogenicity by the in- 
halation route of exposure failed, however, 
to produce any evidence for the carcinoge- 
nicity of DCE in Sprague-Dawley rats or 
Swiss mice (Maltoni et al., 1980). The car- 
cinogenic potential of DCE has, therefore, 
remained somewhat speculative and may, as 
the results of the bioassays suggest, be depen- 
dent on the strains of test animals or the 
route of exposure (Hooper et al., 1980). 
Positive results from several short-term in 
vitro test systems for mutagenicity (Rannug, 
1980; Guengerich et al., 1980; van Bladeren 
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et al., 198 1; Tan and Hsie, 198 1) and primary 
DNA damage (Banerjee and van Duuren, 
1979; Banerjee et al., 1980; Guengerich et 
al., 1980; Perocco and Prodi, 1981) have 
provided further evidence of the carcinogenic 
potential of DCE. More recent studies have 
also confirmed the genotoxic potential of 
DCE in vivo (Reitz et al., 1982; Storer et al., 
1982, 1984; Storer and Conolly, 1983). The 
in vitro studies cited above indicated that 
DCE requires metabolic activation to exhibit 
genotoxic activity and identified two different 
metabolic pathways, glutathione conjugation 
and microsomal oxidation, as potentially sig- 
nificant sources of mutagenic and/or carci- 
nogenic metabolites from DCE. The gluta- 
thione Stransferase-mediated conjugation of 
DCE with glutathione produces reactive 
compounds, presumably half-sulfur mustards, 
which have been shown to be mutagenic 
toward Salmonella typhimurium strains TA 
1535 and TA 100 (Rannug et al., 1978; 
Guengerich et al., 1980; van Bladeren et al., 
198 1). The results from these mutagenicity 
studies and an in vitro DNA binding study 
(Guengerich et al., 1980) have suggested that 
the primary route of bioactivation for DCE 
may be the glutathione conjugation pathway. 
In vitro DNA binding experiments with 
DCE (Banerjee and van Duuren, 1979; Ba- 
nerjee et al., 1980; Guengerich et al., 1980) 
have, however, also provided evidence for 
the involvement of microsomal oxidative 
metabolism in the bioactivation of DCE to 
a genotoxic metabolite. 2Chloroacetalde- 
hyde, which is mutagenic in the Ames test 
without metabolic activation (McCann et al., 
1975), is believed to be the active metabolite 
of DCE formed by this pathway. DNA bind- 
ing studies in vitro have shown that 2-chlo- 
roacetaldehyde reacts directly with adenine 
and cytosine bases to form cyclic etheno 
adducts (Barrio et al., 1972; Lee and Wetmur, 
1973; Guengerich et al., 1981). Further evi- 
dence for the possible importance of 2-chlo- 
roacetaldehyde binding to DNA comes from 
studies demonstrating the presence of 3-p- 
ethenodeoxycytidine (Green and Hathway, 
1978) and 7-N-(2-oxoethyl)guanine (Laib et 
al., 1981) in hydrolysates of DNA from rats 
exposed to vinyl chloride. Vinyl chloride 
metabolism in vitro has been shown to result 
in 2-chloroacetaldehyde production by rear- 
rangement of 2-chloroethylene oxide (Bonse 
et al., 1975) a product of microsomal oxi- 
dative metabolism of vinyl chloride (Barbin 
et al,, 1975). More recently, 2-chloroacetal- 
dehyde pretreatment of nucleotide polymers 
has been shown to induce errors during DNA 
synthesis in vitro (Hall et al., 1981). There 
is, therefore, considerable evidence to suggest 
that microsomal oxidative metabolism of 
DCE to 2-chloroacetaldehyde may also be 
involved in the genotoxicity and carcinoge- 
nicity of DCE. 
Recent sudies in our laboratory have shown 
that DNA single-strand breaks and/or alkali- 
labile lesions can be detected in hepatic DNA 
isolated from mice 4 hr after treatment with 
a single, po or ip dose of DCE (Storer et al., 
1982; Storer and Conolly, 1983). This type 
of DNA damage was not, however, detectable 
in mice exposed by inhalation to concentra- 
tions of DCE as high as 500 ppm for 4 hr 
(Storer et al., 1984). In the present study, the 
role of microsomal oxidative metabolism of 
DCE in the formation of the reactive metab- 
elite(s) responsible for this type of hepatic 
DNA damage was investigated in vivo in two 
different ways. First, the effect of a potent 
inhibitor of microsomal oxidative metabo- 
lism, piperonyl butoxide (PIB), on the hepatic 
DNA damage produced by DCE was studied. 
Second, the potential of 2-chloroethanol to 
produce single-strand breaks and/or alkali- 
labile lesions in hepatic DNA from mice 
treated in vivo was investigated. 2Chloroeth- 
anol is metabolized by alcohol dehydrogen- 
ases to 2-chloroacetaldehyde (Blair and Valee, 
1966; Johnson, 1967) and was employed in 
these studies as a means of generating 2- 
chloroacetaldehyde intracellularly in vivo. The 
acute toxicity of 2-chloroacetaldehyde in vivo 
and evidence of its reactivity at the site of 
administration (Lawrence et al., 1972) indi- 
cated that it would not be feasible to inves- 
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tigate the in vivo genotoxicity of this com- 
pound directly. 
METHODS 
Animals. Male B6C3Fi mice were purchased from 
Charles River Breeding Laboratories, Inc., Portage, 
Michigan, or were bred in our laboratories from C3H 
male and C57BL female mice obtained from Charles 
River Breeding Laboratories, Inc. Mice were 6 to 9 
weeks of age at the time of experiments and had been 
maintained in our laboratory for at least 3 weeks prior 
to use. Mice were housed 8 to 10 per cage, bedded in 
soft wood chips, and fed Purina rodent chow and water 
ad libitum until the morning of experiments. Animal 
rooms were maintained at 22 to 24°C with a 12 hr 
light-dark cycle. DCE and PIB were administered ip in 
corn oil in a constant volume of 5 and 1 ml/kg, 
respectively. 2Chloroethanol was dissolved in 0.85% 
NaCl and administered ip in a constant volume of 5 ml/ 
kg. Diethyl maleate (DEM) was administered ip (neat). 
Carbon tetrachloride (CCh) was given ip in corn oil in 
a constant volume of 5 ml/kg. 
Chemicals. DCE (glass distilled) was purchased from 
MCB Manufacturing Chemists, Inc., Cincinnati, Ohio. 
Its purity was checked by gas chromatography (flame 
ionization detector) and found to be greater than 99.9%. 
PIB was obtained from ICN Pharmaceuticals, Plainview, 
New York. 2Chloroethanol and diaminobenzoic acid 
dihydrcchloride were purchased from Aldrich Chemicals, 
Milwaukee, Wisconsin. DEM, glutathione reductase, re- 
duced glutathione (GSH), oxidized ghttathione (GSSG), 
NADH, and NADPH were all obtained from the Sigma 
Chemical Company, St. Louis, Missouri. Hexobarbital 
was purchased from Winthrop Steams Inc., New York, 
New York, and 2-vinylpyridine from Fluka AG, Buchs, 
Switzerland. The hydroxylapatite (Bio-Gel HTP, DNA 
grade) was obtained from Bio-Rad Laboratories, Rich- 
mond, California. 
Hexobarbital sleeping time. Hexobarbital (free acid, 
125 mg) was added to 1.5 ml of 0.85% NaCI, and 5- to 
25 ~1 aliquots of 5.0 N NaOH were added until the 
hexobarbital dissolved. The solution was then diluted to 
2.0 ml. Mice were injected ip with 2.0 ml/kg of this 
solution (125 mg/kg), and the hexobarbital sleeping time 
was measured as the time from loss of the righting reflex 
to its restoration, as previously described (Vesell, 1968). 
Hepatic glututhione levels. Oxidized glutathione (GSSG) 
and total glutathione (GSSG and GSH) per gram of liver 
tissue were determined by a ghrtathione reductase recy- 
cling assay (Tietze, 1969). The procedure, described 
below, is a modification of the techniques developed by 
Griffith (1980) and Akerboom and Sies (1981). Mice 
treated as described in the text were killed by cervical 
dislocation and the livers removed and homogenized in 
9 vol of cold 1.0 M HCIO., and 2.0 mM EDTA-Na,. 
Homogenates were centrifuged at 3500g for 15 min at 
4°C and the supematant fractions diluted either l/10 
for determination of GSSG or l/100 for determination 
of total glutathione (GSH and GSSG). Aliquots (690 ~1) 
of these dilutions were then transferred to separate tubes 
containing 410 ~1 of 2.0 M KOH and 0.3 M Hepes; the 
precipitate was pelleted by centrifugation for 15 min at 
35008. For the determination of GSSG, 10.5 ~1 of 2- 
vinylpyridine was added to each tube with the 2.0 M 
KOH. 0.3 M Hepes to derivatize the GSH. The super- 
natant fraction in each tube was then assayed for gluta- 
thione by the glutathione reductase recycling assay. An 
aliquot (700 ~1) of 0.1 M sodium phosphate, 5.0 mM 
EDTA-Naz buffer, pH 7.5, containing 0.3 mM NADPH, 
was transferred to a 1.5-ml cuvette containing 20 ~1 of 
3.8 mM 5,5’dithiobis-2-nitrobenzoic acid (DTNB) in 0.1 
M sodium phosphate, 5 mM EDTA-Na, buffer, pH 7.5, 
and 200 r.d of neutralized supematant fraction. To start 
the assay, 40 ~1 of GSH reductase (12.5 units/ml in 0.1 
M sodium phosphate, 50 mM EDTA-Na2 buffer, pH 7.5) 
was added and the absorbance at 412 nm monitored for 
5 min at 25°C. The glutathione content of the samples 
was then determined from standard curves for the rate 
of change of the absorbance at 412 nm for standards 
containing known amounts of GSSG or GSH. The GSH 
concentration in the samples was calculated as the 
difference between the total glutathione (GSH and GSSG) 
and oxidized ghttathione (GSSG) per gram of tissue. 
Acute toxicity. To assess the acute toxicity of DCE 
and 2-chloroethanol alone and with PIB and DEM 
pretreatments, respectively, mice were treated as described 
in the text and killed 24 hr later. Feed but not water 
was removed during the interval between dosing and 
termination. Liver and kidneys were removed and 
weighed; blood was drawn for determination of serum 
enzyme levels. L-Iditol dehydrogenase (IDH, sorbitol 
dehydrogenase, EC 1.1.1.14) activity in serum was ana- 
lyzed according to the method described by Conolly et 
al. (1979) and serum alanine aminotransferase (AAT, 
EC 2.6.1.2) activity by the method of Wroblewski and 
LaDue (1956). 
In vivo-in vitro genotoxicity assay. In vivo genotoxicity 
was determined with a sensitive in vivo-in vitro alkaline 
DNA unwinding assay for the presence of single-strand 
breaks and alkali-labile sites in hepatic DNA (Storer and 
Conolly, 1983, 1984). Mice were treated as described in 
the text and killed 4 hr later by cervical dislocation. 
Hepatic DNA damage measured as single-strand breaks 
in alkali has previously been shown to be maximal 4 hr 
after administration of a genotoxic 1,2dihaloethane, I ,2- 
dibromoethane (Nachtomi and Sarma, 1977). Livers 
were removed and suspensions of hepatic nuclei prepared 
by gently mincing livers in cold 0.075 M NaCl and 0.024 
M EDTA-Naz, pH 7.5. The presence of single-strand 
breaks and/or alkali-labile lesions in the hepatic DNA 
was then determined by alkaline DNA unwinding and 
hydroxylapatite batch chromatography as previously de- 
scribed (Storer and Conolly, 1983, 1984). For each 
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sample of nuclei, assayed in duplicate, the fraction of 
the total DNA recovered which eluted from the hydrox- 
ylapatite as double-stranded DNA was calculated. Results 
for each animal were then expressed as a percentage of 
the mean value for the fraction of the DNA that is 
double stranded in the control group and results for each 
group as the mean and standard deviation of these 
percentages. 
Statistical analysis. Mean and standard deviations 
were calculated for each experimental group. Significance 
testing was by one-way analysis of variance with multiple 
comparisons by the Bonferroni method (Neter and Was- 
serman, 1974). Statistical significance was assumed at 
the p c 0.05 level. 
RESULTS 
Hexobarbital sleeping times have previ- 
ously been shown to be a convenient measure 
of microsomal cytochrome P-450-mediated, 
monooxygenase activity in vivo (Conney et 
al., 1960). Results presented in Table 1 in- 
dicate that PIB, at the dose levels employed 
in these studies, significantly inhibited micro- 
somal oxidative metabolism of hexobarbital 
as evidenced by the approximately lo-fold 
increase in observed hexobarbital sleeping 
times. Similar results for the effect of PIB on 
hexobarbital sleeping times in male mice 
have been reported earlier (Kamienski and 
Murphy, 1971). Whereas DCE metabolism 
has previously been shown to be dependent 
on cytochrome P-450-mediated monooxy- 
genase activity (Guengerich et al., 1980) and 
TABLE 1 
EFFECT OF PIPERONYL BUTOXIDE PRETREATMENT 




Corn oil 69 f  9 
PIB 659 f  135’ 
a PIB (200 mg/kg) or corn oil was administered ip to 
3 male B6C3Fi mice per group 1 hr before hexobarbital. 
b Hexobarbital(125 mg/kg) was administered ip. Values 
are X f  SD. 
‘Significantly different from control (p < 0.05) by 
one-way analysis of variance (Neter and Wasserman, 
1974). 
to be inhibited by the classic cytochrome P- 
450 inhibitors, SKF-525A and metyrapone 
(Guengerich et al., 1980), these results indi- 
cate that the PIB pretreatment employed in 
these studies would be expected to have 
significantly inhibited microsomal oxidative 
metabolism of DCE in vivo. 
The effect of PIB pretreatment on hepatic 
glutathione levels was also investigated in 
preliminary experiments to determine if the 
previously reported depletion of hepatic glu- 
tathione by PIB in mice (James and Harbison, 
1982) would be observed at the dose levels 
required to inhibit microsomal oxidative me- 
tabolism. No significant changes in hepatic 
glutathione levels were observed, however, in 
groups of three mice 1.5, 3.0, or 4.5 hr after 
a single, 200-mg/kg dose of PIB. These results 
indicated that hepatic glutathione depletion 
would not be a significant confounding factor 
in the genotoxicity experiments. 
Acute hepatotoxicity may under certain 
circumstances be a confounding factor in 
hepatic DNA damage studies where the end- 
point employed is single-strand breaks in 
alkali (Sina et al., 1983). We have previously 
found that a single, ip dose of CC& (25 pl/ 
kg) which produces evidence of severe hepa- 
totoxicity at 24 hr did not have any significant 
effect on DNA strand integrity as early as 4 
hr after treatment (Storer, et al., 1984). Nev- 
ertheless, the acute hepatotoxicity of the 
treatment regimens employed in the in vivo 
genotoxicity studies reported here was inves- 
tigated in separate experiments. Results pre- 
sented in Table 2 indicate that neither DCE 
nor PIB, alone or in combination, was acutely 
hepatotoxic at the doses employed in these 
studies. Liver weight to body weight ratios 
were elevated after PIB treatment but this 
effect, reported previously (Philpot and 
Hodgson, 197 l), is believed to be due to the 
inductive effect of PIB on microsomal en- 
zymes rather than to acute hepatotoxicity. 
The effect of PIB pretreatment on the 
extent of hepatic DNA damage produced by 
DCE is shown in Table 3. Administration of 
PIB alone did not produce any evidence of 
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TABLE 2 















4.44 + 0.34 9.8 + 1.2 7.3 f  1.5 1.47 + 0.10 











4.40 * 0.14 10.8 + 2.6 4.6 2 0.8 1.41 f  0.02 
5.18 f  0.22d 8.8 f  0.6 6.7 + 1.0 1.52 +- 0.06 
6.23 f  0.53d 5821.0 + 1565.5” 2590.0 f  731.9d 1.51 f  0.09 
’ B6C3F, male mice were killed 24 hr after ip administration of DCE or corn oil. PIB was injected ip 1 hr before 
DCE or corn oil. All values are X f  SD for 3 to 5 mice per group. 
’ Organ weight per 100 g body wt. 
’ IDH, L-iditol dehydrogenase (EC I. 1. I. 14); AAT, alanine aminotransferase (EC 2.6.1.2). 
d Significantly different from control (p c 0.05) by one-way analysis of variance with multiple comparisons by 
the Bonferroni method (Neter and Wasserman, 1974). 
DNA strand breaks in alkali but, as previously 
reported (Storer and Conolly, 1983) DCE 
alone significantly decreased the fraction of 
TABLE 3 
IN Vwo GENOTOXI~ITY OF I ,2-DI~HL~R~ETHANE: 
EFFECT OF PRETREATMENT WITH PIPERONYL BUTOXIDE’ 
Fraction double- 
Pretreat- stranded DNA b 5% 
Compound ment (% of control) Change’ 
Corn oil Corn oil 100.0 f. 3.3 (12) - 
Corn oil PIB 99.7 f  3.8 (4) -0.3 
DCE Corn oil 76.2 k 4.7* (8) -23.8 
DCE PIB 69.4 f  8. I dx (8) -30.6 
a Male B6C3Fr mice were killed 4 hr after ip admin- 
istration of DCE (200 mg/kg) or corn oil. PIB (200 mg/ 
kg) was injected ip I hr before DCE or corn oil. 
’ Values are X + SD. The mean value for the fraction 
double-stranded DNA in the control group was 0.637 
f  0.040. Numbers of mice per group are in parentheses. 
’ Control minus treated. 
dSignificantly different from control (p G 0.05) by 
one-way analysis of variance with multiple comparisons 
by the Bonferroni method (Neter and Wasserman, 1974). 
‘Significantly different from mice treated with DCE 
alone (p 4 0.05) by one-way analaysis of variance with 
multiple comparisons by the Bonferroni method (Neter 
and Wasserman, 1974). 
the total DNA recovered as double-stranded 
DNA. However, when mice were pretreated 
with PIB, the genotoxic effect of DCE was 
potentiated. The fraction of the total DNA 
recovered as double-stranded DNA, expressed 
as a percentage of control, was significantly 
decreased in the PIB-pretreated animals after 
DCE administration. Thus, it would appear 
that microsomal, cytochrome P-450-me- 
diated, oxidative metabolism is not the pri- 
mary source of the genotoxic metabolite(s) 
responsible for this type of DNA damage. 
Previous studies of the metabolism of DCE 
in viva in mice (Yllner, 1971) and rats (Reitz 
et al., 1982) indicated that oxidative metab- 
olism is a major route of disposition for 
DCE. The identities of the major urinary 
metabolites recovered in these studies (chlo- 
roacetic acid, S-carboxymethylcysteine, 
thiodiacetic acid, and thiodiacetic acid sulf- 
oxide) indicate that microsomal oxidative 
metabolism of DCE and subsequent conju- 
gation of the oxidative metabolites with glu- 
tathione are involved in the generation of a 
significant fraction of these urinary metabo- 
lites. We have previously found significant 
depletion of hepatic glutathione levels in 
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mice treated with DCE (Storer er al., 1982). 
Since this depletion is probably due largely 
to the conjugation of glutathione with oxi- 
dative metabolites of DCE, the assumed in- 
hibitory effect of PIB on DCE metabolism 
should be evident as a decrease in the extent 
of hepatic glutathione depletion. This phe- 
nomenon has been observed in PIB-pretreated 
mice dosed with 1,2-dibromoethane (Kluwe 
et al., 198 1). Results presented in Fig. 1 
indicate that PIB pretreatment does signifi- 
cantly inhibit the glutathione depleting effect 
of DCE at 1 hr after DCE administration 
but the magnitude of the effect is quite small. 
This may be evidence of a compensatory 
increase in the amount of DCE metabolized 
by the direct glutathione conjugation pathway 
after PIB pretreatment. 
In the second series of experiments in this 
study, the in vivo genotoxicity of 2-chloroeth- 
anol was investigated. 2-Chloroethanol has 
been identified as a metabolite of DCE in 
I  
1.0 2.0 
HOURS AFTER DCE 
FIG. I. Time course of hepatic ghttathione depletion 
in male B6C3F, mice after ip injection of DCE (200 
mg/kg) alone or with PIB pretreatment. PIB (200 mg/ 
kg) was injected ip I hr before DCE. Each point represents 
d k SD for 4 mice. *Significantly different from mice 
treated with DCE alone (P < 0.05) by one-way analysis 
of variance. Control hepatic glutathione concentrations 





1.0 2.0 3.0 
HOURS AFTER P-CHLOROETHANOL 
FIG. 2. Time course of hepatic glutathione depletion in 
male B6C3F, mice after ip injection of 2-chloroethanol. 
Each point represents the 1 f  SD for 4 male B6C3Fi 
mice. Control hepatic glutathione was 9.62 + 0.74 pmol/ 
g liver. 
vitro (Guengerich et al., 1980) and has been 
shown to be a substrate for alcohol dehydro- 
genases (Johnson, 1967; Guengerich et al., 
1979). Thus, in vivo administration of 2- 
chloroethanol would be expected to lead to 
the formation of 2-chloroacetaldehyde intra- 
cellularly in hepatocytes, the major target 
cell population in this study. Since 2-chlo- 
roacetaldehyde is more readily conjugated 
with glutathione than 2-chloroethanol (John- 
son, 1966), hepatic glutathione depletion is 
a convenient indicator of the extent of for- 
mation of 2-chloroacetaldehyde in vivo and 
was determined in these studies as a means 
of choosing appropriate dose levels for the in 
vivo genotoxicity experiments. Results pre- 
sented in Fig. 2 indicate that hepatic gluta- 
thione levels are depleted below 30% of con- 
trol values 1.5 hr after a single ip dose of 0.9 
mmol/kg of 2-chloroethanol. Whereas the 
published LDsO for ip administration of 2- 
chloroethanol to male mice is 1.2 mmol/kg 
(Lawrence et al., 1972), a range of dose levels 
from 0.9 to 1.2 mmol/kg was selected for the 
in vivo genotoxicity experiments. 
The acute toxicity of 2-chloroethanol in 
this dose range was investigated in separate 
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TABLE 4 
ACUTETOXICITYOF~-CHLOROETHANOLIN B6C3F, MALEMICE" 
Liver Serum IDH' Serum AAT’ Kidney 
Compound Pretreatment weightb W/l) NJ/l) weight’ Mortality 
Saline - 4.74 f  0.28 8.4 f  1.1 5.4 f  2.5 1.43 f  0.04 016 
2Chloroethano1, 
0.3 mmol/kg - 4.43 f  0.32 11.9 f  1.5 4.8 + 1.9 1.44 f  0.08 O/3 
2-Chloroethanol, 
0.6 mmol/kg - 4.40 f  0.06 8.4 f  0.6 2.9 f  0.5 1.36 f  0.09 O/3 
2-Chloroethanol, 
0.9 mmol/kg - 4.53 + 0.09 9.8 f  1.9 5.1 f  0.3 1.43 f  0.08 O/3 
2-Chloroethanol, 
1.2 mmol/kg - 5.52 f  0.52d 16.6 2k 3.0d 17.8 + 8.gd 1.50 + 0.05 O/5 
2-Chloroethanol, Diethyl maleate 6.4 1 f  0.4 1 d 34.7 + 1.7d 25.5 f  8.1d 1.49 ? 0.06 214 
0.9 mmol/kg 3.0 mmol/kg 
CC&, 25 /J/kg - 6.23 + 0.53d 5821.0 + 1565.5d 2590.0 f  731.9d 1.51 f  0.09 O/3 
n Male B6C3Fi mice were killed 24 hr after ip administration of DCE, saline, or CC&. Diethyl maleate was 
administered ip 1 hr before 2-chloroethanol. All values are X f  SD for 3 to 6 B6C3Fi mice per group. 
b Organ weight per 100 g body wt. 
’ IDH, L-iditol dehydrogenase (EC 1.1.1.14); AAT, alanine aminotransferase (EC 2.6.1.2). 
dSignilicantly different from control, (P < 0.05) by one-way analysis of variance with multiple comparisons by 
the Bonferroni method (Neter and Wasserman, 1974). 
experiments. Results presented in Table 4 
indicate that 2-chIoroethanol was hepatotoxic 
only at the highest dose level tested, 1.2 
mmol/kg. Pretreatment with DEM poten- 
tiated the acute toxicity of 2-chloroethanol 
indicating, as expected, a protective effect of 
glutathione. Mice pretreated with 3.0 mmol/ 
kg of diethyl maleate 1 hr before 0.9 mmol/ 
kg of 2-chloroethanol experienced high mor- 
tality and significantly increased liver to body 
weight ratios and serum enzyme activities. 
The results of the in vivo genotoxicity 
experiments with 2-chloroethanol are pre- 
sented in Table 5. Four hours after ip ad- 
ministration of 2-chloroethanol at doses as 
high as 1.2 mmol/kg, there was no evidence 
of single-strand breaks and/or alkali-labile 
lesions in hepatic DNA. Pretreatment of 
mice with DEM to deplete hepatic glutathione 
prior to 2-chloroethanol administration also 
failed to produce a significant genotoxic effect. 
These results strongly suggest that 2-chloro- 
ethanol and 2-chloroacetaldehyde are not 
responsible for the hepatic DNA damage 
observed in these studies 4 hr after DCE 
administration. 
DISCUSSION 
PIB is a potent inhibitor of cytochrome P- 
450 monooxygenase activity. A methylene- 
dioxyphenyl compound, it forms stable, met- 
abolic intermediate complexes with cyto- 
chrome P-450 both in vitro and in vivo 
(Franklin, 1977). The potentiation of the in 
vivo genotoxicity of DCE observed after PIB 
pretreatment therefore suggests that either 
the overall flux of DCE through an alternate 
bioactivation pathway is increased or the 
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TABLE 5 
IN VIVO GEN~T~XICI~ OF &CHLOROETHANOL” 
Fraction double- 
stranded DNA 96 




loo.0 + 5.4 (9) 
99.1 k 6.0(4) -0.9 
2-Chloroethano1, - 
1.05 mmol/kg 
99.4 f 4.1 (4) -0.6 
2-Chloroethano1, - 
1.20 mmol/kg 
104.1 f 6.8 (5) +4.1 
2-Chloroethanol, Diethyl 97.8 + 9.4 (5) -2.2 
0.9 mmol/kg maleate, 3.0 
mmol/kg 
a Male B6C3F, mice were dosed ip with saline or Z-chloroe- 
thanol and killed 4 hr later. Diethyl maleate was administered 
ip I hr before 2shloroethanol. 
b Values are X 2 SD. The mean value for the h-action double- 
stranded DNA in the control group was 0.579 ? 0.03 I. Numbers 
of mice per group are in parentheses. 
c Control minus treated. 
activity of a detoxification pathway is de- 
creased as a consequence of the inhibition of 
microsomal, cytochrome P-450-mediated, 
oxidative metabolism. However, since micro- 
somal oxidative metabolism is not known to 
be involved in the detoxification of any of 
the known or suspected reactive metabolites 
of DCE, it would appear that the data indicate 
an enhanced activity of an alternate pathway 
of metabolic activation. The only other ac- 
tivation pathway for DCE that has been 
identified to date is the direct conjugation of 
DCE with glutathione mediated by the glu- 
tathione S-transferases. Thus, it would appear 
that the most plausible explanation for the 
potentiation of the in vivo genotoxicity of 
DCE observed after PIB pretreatment is an 
increase in the total amount of reactive me- 
tabolites generated by the glutathione con- 
jugation pathway. 
White et al. (1983) have recently shown 
that deuterium substitution inhibits the mi- 
crosomal oxidative metabolism of 1,2-di- 
bromoethane (DBE) in vitro and decreases 
its rate of clearance from the liver in vivo. 
When the genotoxicities of DBE and tetra- 
deutero-DBE were compared in an in vivo 
assay for single-strand breaks and alkali-labile 
lesions in DNA (alkaline elution), these au- 
thors found that the deuterium substitutions 
significantly increased the genotoxicity of 
DBE. They concluded, as we have here for 
DCE, that the increased genotoxicity, ob- 
served under conditions where microsomal 
oxidative metabolism was inhibited, strongly 
suggests that a product of the direct glutathi- 
one conjugation pathway is responsible for 
the hepatic DNA damage observed. The pro- 
longed availability of DBE in the liver for 
glutathione conjugation was cited as a likely 
explanation for the potentiating effect of deu- 
terium substitution. Thus, two, independent 
investigations of the role of microsomal oxi- 
dative metabolism in the in vivo genotoxicity 
of 1,2-dihaloethanes have produced similar 
results which suggest a primary role for active 
metabolites of the glutathione conjugation 
pathway in the production of the single- 
strand breaks observed in alkaline DNA frag- 
mentation assays. In addition, Ozawa and 
Guengerich ( 1983) have demostrated the for- 
mation of an 9[2-(N’-guanyl)ethyl]gluta- 
thione adduct in DNA incubated with DBE, 
GSH, and glutathione Stransferases. 
The negative results from the in vivo geno- 
toxicity assays of 2-chloroethanol provide 
further evidence for the primary role of the 
glutathione conjugation pathway in the in 
vivo genotoxicity of DCE. The glutathione 
depleting effect of 2-chloroethanol in vivo 
strongly suggests the intracellular production 
of significant amounts of 2-chloroacetalde- 
hyde since, as shown by Johnson (1966), 2- 
chloroethanol itself is not a good substrate 
for glutathione S-transferase. The negative 
results might suggest that glutathione conju- 
gation effectively detoxifies the 2-chloroacet- 
aldehyde formed before it can diffuse to the 
nucleus, but no hepatic DNA damage was 
seen after pretreatment with 3.0 mmol/kg 
DEM. This pretreatment reduced the hepatic 
glutathione level to 30% of control values at 
1 hr (unpublished data) when the 2-chloro- REFERENCES 
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